<?xml version="1.0" encoding="UTF-8"?>
<p>To date, yellow fever treatment consists of intensive support by providing hydration, blood transfusions and, eventually, renal replacement therapy
 <sup>
  <xref rid="B47" ref-type="bibr">47</xref>
 </sup> . Some studies have shown that therapy remains limited to symptomatic care in hospitals, and, in the most severe forms of the disease, patients must be treated in intensive care units. Unfortunately, even though different molecules (polyclonal anti-YFV, target viral factors and immunomodulatory compounds) have shown some activity against the virus, both 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> , they are not yet available for clinical use and have not been approved, as well
 <sup>
  <xref rid="B14" ref-type="bibr">14</xref> , 
  <xref rid="B35" ref-type="bibr">35</xref>
 </sup> .
</p>
